$BCYC

Bicycle Therapeutics Plc

Nasdaq · Healthcare · Pharmaceutical Preparations · Cambridge, United Kingdom

BCYC chart

What traders are saying about $BCYC

Latest posts

Bicycle Therapeutics Plc news

Bicycle Therapeutics Plc key financials

USD2025202420232022
Revenue$72.6M$35.3M$27.0M$14.5M
Net income-$219.0M-$169.0M-$180.7M-$112.7M
Diluted EPS$-3.16$-2.90$-5.08$-3.80
Total assets (year end)$717.6M$956.9M$595.3M$410.6M
Cash and equivalents (year end)$628.1M$879.5M$526.4M$339.2M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Bicycle Therapeutics Plc

Ticker
BCYC (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Cambridge, United Kingdom
Incorporated in
United Kingdom
Fiscal year end
December 31
SEC CIK
1761612
Former names
BICYCLE THERAPEUTICS Ltd

Frequently asked questions

What exchange is Bicycle Therapeutics Plc listed on?

Bicycle Therapeutics Plc trades on the Nasdaq under the ticker symbol BCYC.

What industry is Bicycle Therapeutics Plc in?

Bicycle Therapeutics Plc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Bicycle Therapeutics Plc headquartered?

Bicycle Therapeutics Plc's business address on file with the SEC is in Cambridge, United Kingdom.

When does Bicycle Therapeutics Plc's fiscal year end?

Bicycle Therapeutics Plc's fiscal year ends on December 31.

How much revenue did Bicycle Therapeutics Plc report?

Bicycle Therapeutics Plc reported $72.6M in revenue for calendar year 2025, according to its SEC filings.